- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00930319
Effectiveness and Safety of Firmagon® (FAST)
November 8, 2023 updated by: Ferring Pharmaceuticals
Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma
Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma.
The period until Prostate Specific Antigen (PSA) progression during the Firmagon® therapy is to be documented and related to the testosterone values measured in the course of therapy (if available).
Other clinical parameters, the patients' quality of life and the direct and indirect costs incurred by the medical care for the advanced hormone-dependent prostate carcinoma and its consequences will be evaluated.
In this context the medical outcome and the life quality are defined as effectiveness and benefit value parameters.
Both the effectiveness under daily life circumstances and economic variables of the therapy can thus be shown and compared within an analysis of costs vs. benefits or costs vs. effectiveness.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
676
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aalen, Germany
- Investigational Site, Heinrich-Rieger-Str. 15
-
Aalen, Germany
- Investigational Site, Weidenfelder Straße 1
-
Abensberg, Germany
- Investigational Site
-
Ahaus, Germany
- Investigational Site
-
Ahrensburg, Germany
- Investigational Site
-
Alsdorf, Germany
- Investigational Site
-
Alsfeld, Germany
- Investigational Site
-
Altenburg, Germany
- Investigational Site
-
Andernach, Germany
- Investigational Site
-
Ansbach, Germany
- Investigational Site, Endresstraße 12
-
Ansbach, Germany
- Investigational Site, Platenstraße 15
-
Augsburg, Germany
- Investigational Site, Frölichstraße 13
-
Augsburg, Germany
- Investigational Site, Prinzregentenstraße 4
-
Bad Godesberg, Germany
- Investigational Site
-
Bad Marienberg, Germany
- Investigational Site
-
Bad Oldesloe, Germany
- Investigational Site
-
Bad Salzuflen, Germany
- Investigational Site
-
Bad Schönborn, Germany
- Investigational Site
-
Bad Wildungen, Germany
- Investigational Site
-
Bautzen, Germany
- Investigational Site
-
Bergzabern, Germany
- Investigational Site
-
Berlin, Germany
- Investigational Site, Albert-Einstein-Straße 2
-
Berlin, Germany
- Investigational Site, Allee der Kosmonauten 47
-
Berlin, Germany
- Investigational Site, Hohenzollerndamm 47a
-
Berlin, Germany
- Investigational Site, Lipschitzallee 20
-
Berlin, Germany
- Investigational Site, Mehrower Allee 22
-
Berlin, Germany
- Investigational Site, Pasteurstraße 8
-
Berlin, Germany
- Investigational Site, Rudolff-Seifert-Straße 11
-
Berlin, Germany
- Investigational Site, Wisbyer Straße 16
-
Biberach, Germany
- Investigational Site, Zeppelinring 7
-
Biedenkopf, Germany
- Investigational Site
-
Bielefeld, Germany
- Investigational Site, Elbeallee 83
-
Bielefeld, Germany
- Investigational Site, Friedrich-Verleger Straße 5
-
Bielefeld, Germany
- Investigational Site, Johannisstraße 43
-
Bielefeld, Germany
- Investigational Site, Treppenstraße 3
-
Bitterfeld, Germany
- Investigational Site
-
Bocholt, Germany
- Investigational Site
-
Bonn, Germany
- Investigational Site, St. Augustiner-Straße 21
-
Bonn, Germany
- Investigational Site, Trierer Straße 70 - 72
-
Borken, Germany
- Investigational Site
-
Bramsche, Germany
- Investigational Site
-
Braunschweig, Germany
- Investigational Site
-
Bremen, Germany
- Investigational Site
-
Bremerhaven, Germany
- Investigational Site, Dr.-Franz-Mertens-Straße 8
-
Bremerhaven, Germany
- Investigational Site, Georgstraße 44
-
Bruchköbel, Germany
- Investigational Site
-
Buchholz, Germany
- Investigational Site
-
Burg, Germany
- Investigational Site
-
Bünde, Germany
- Investigational Site
-
Celle, Germany
- Investigational Site
-
Chemnitz, Germany
- Investigational Site, Carl-von-Ossietzky-Str. 151
-
Chemnitz, Germany
- Investigational Site, Clausstraße 44
-
Chemnitz, Germany
- Investigational Site, Flemmingstraße 1b
-
Chemnitz, Germany
- Investigational Site, Unritzstraße 21 c
-
Coburg, Germany
- Investigational Site
-
Cottbus, Germany
- Investigational Site
-
Crailsheim, Germany
- Investigational Site, Karlstraße 30
-
Crailsheim, Germany
- Investigational Site, Postplatz 2
-
Delitzsch, Germany
- Investigational Site
-
Dessau, Germany
- Investigational Site
-
Dessau-Roßlau, Germany
- Investigational Site
-
Dillenburg, Germany
- Investigational Site
-
Dinslaken, Germany
- Investigational Site
-
Dortmund, Germany
- Investigational Site
-
Dossenheim, Germany
- Investigational Site
-
Dresden, Germany
- Investigational Site
-
Duisburg, Germany
- Investigational Site, Kreuzstraße 3-5
-
Duisburg, Germany
- Investigational Site, Königstraße 49
-
Dülmen, Germany
- Investigational Site
-
Düsseldorf, Germany
- Investigational Site
-
Eisenhüttenstadt, Germany
- Investigational Site
-
Erfurt, Germany
- Investigational Site, Geschwister-Scholl-Str. 6
-
Erfurt, Germany
- Investigational Site, Juri-Gagarin-Ring 94
-
Essen, Germany
- Investigational Site
-
Finsterwalde, Germany
- Investigational Site
-
Frankfurt, Germany
- Investigational Site, Eschersheimer Landstr. 544
-
Frankfurt, Germany
- Investigational Site, Im Steinbügel 13
-
Freiburg, Germany
- Investigational Site
-
Freital, Germany
- Investigational Site
-
Friedberg, Germany
- Investigational Site
-
Friedrichshafen, Germany
- Investigational Site
-
Gelsenkirchen, Germany
- Investigational Site, Arminstraße 24
-
Gelsenkirchen, Germany
- Investigational Site, Feldmarkstraße 109
-
Gelsenkirchen, Germany
- Investigational Site, Zum Ehrenmal 21
-
Gera, Germany
- Investigational Site
-
Gießen, Germany
- Investigational Site
-
Gotha, Germany
- Investigational Site, Helenenstraße 10-12
-
Gotha, Germany
- Investigational Site, Schützenberg 10
-
Grimma, Germany
- Investigational Site
-
Halle, Germany
- Investigational Site, Niemeyerstraße 23
-
Halle, Germany
- Investigational Site, Reilstraße 129 a
-
Halle (Saale), Germany
- Investigational Site, Steinweg 27
-
Hamburg, Germany
- Investigational Site, Alte Holstenstraße 16
-
Hamburg, Germany
- Investigational Site, Fuhlsbüttler Straße 182
-
Hamburg, Germany
- Investigational Site, Grindelberg 3
-
Hamburg, Germany
- Investigational Site, Herthastraße 12
-
Hamburg, Germany
- Investigational Site, Tangstedter Landstraße 77
-
Hattersheim, Germany
- Investigational Site
-
Heidelberg, Germany
- Investigational Site
-
Heilbronn, Germany
- Investigational Site
-
Heinsberg, Germany
- Investigational Site
-
Hennigsdorf, Germany
- Investigational Site
-
Herford, Germany
- Investigational Site
-
Hof, Germany
- Investigational Site, Enoch-Widmann-Straße 5
-
Hof, Germany
- Investigational Site, Eppenreuther Straße 28
-
Isenburg, Germany
- Investigational Site
-
Jena, Germany
- Investigational Site
-
Jülich, Germany
- Investigational Site
-
Kaiserslautern, Germany
- Investigational Site
-
Kamenz, Germany
- Investigational Site
-
Kamp-Lintfort, Germany
- Investigational Site
-
Karlsruhe, Germany
- Investigational Site
-
Kempten, Germany
- Investigational Site
-
Kiel, Germany
- Investigational Site, Markt 11
-
Kiel, Germany
- Investigational Site, Prüner Gang 15
-
Kiel, Germany
- Investigational Site, Schulstraße 7
-
Kleinblittersdorf, Germany
- Investigational Site
-
Krefeld, Germany
- Investigational Site
-
Kulmbach, Germany
- Investigational Site
-
Köln, Germany
- Investigational Site, Custodistraße 3-17
-
Köln, Germany
- Investigational Site, Wilhelm-Ewald-Weg 1
-
Köln, Germany
- Investigational Site, Zeppelinstraße 1
-
Köthen, Germany
- Investigational Site, Friederikenstraße 30
-
Köthen, Germany
- Investigational Site, Siebenbrünnenpromenade 6-7
-
Lampertheim, Germany
- Investigational Site
-
Langenau, Germany
- Investigational Site
-
Lebach, Germany
- Investigational Site
-
Leutkirch, Germany
- Investigational Site
-
Lichtenfels, Germany
- Investigational Site
-
Limbach-Oberfrohna, Germany
- Investigational Site
-
Ludwigshafen, Germany
- Investigational Site
-
Lübbenau, Germany
- Investigational Site
-
Lübeck, Germany
- Investigational Site
-
Lüneburg, Germany
- Investigational Site
-
Lünen, Germany
- Investigational Site
-
Magdeburg, Germany
- Investigational Site
-
Mainz, Germany
- Investigational Site
-
Mannheim, Germany
- Investigational Site, N7, 9
-
Mannheim, Germany
- Investigational Site, Seckenheimer Hauptstraße 107
-
Marburg, Germany
- Investigational Site
-
Marl, Germany
- Investigational Site
-
Mechernich, Germany
- Investigational Site
-
Merseburg, Germany
- Investigational Site
-
Merzig, Germany
- Investigational Site
-
Michelstadt, Germany
- Investigational Site
-
Miltenberg, Germany
- Investigational Site
-
Moers, Germany
- Investigational Site
-
Mölln, Germany
- Investigational Site
-
Mörlenbach, Germany
- Investigational Site
-
Mühlacker, Germany
- Investigational Site
-
Mühlhausen, Germany
- Investigational Site
-
Mühlheim, Germany
- Investigational Site
-
Münster, Germany
- Investigational Site, Fürstenbergstraße 5
-
Münster, Germany
- Investigational Site, Hohenzollernring 70
-
Naumburg, Germany
- Investigational Site
-
Neu-Ulm, Germany
- Investigational Site
-
Neunkirchen, Germany
- Investigational Site
-
Neuss, Germany
- Investigational Site
-
Nienburg, Germany
- Investigational Site
-
Norderstedt, Germany
- Investigational Site
-
Nordhausen, Germany
- Investigational Site, Bahnhofstraße 17
-
Nordhausen, Germany
- Investigational Site, Bahnhofstraße 8
-
Nordhorn, Germany
- Investigational Site, Am Museumsturm 4
-
Nordhorn, Germany
- Investigational Site, Osnabrücker Straße 1
-
Nürnberg, Germany
- Investigational Site, Am Stadtpark 2
-
Nürnberg, Germany
- Investigational Site, Hefnersplatz 1
-
Nürnberg, Germany
- Investigational Site, Kopernikusplatz 7
-
Obernburg, Germany
- Investigational Site
-
Ochsenfurt, Germany
- Investigational Site
-
Offenbach am Main, Germany
- Investigational Site
-
Osnabrück, Germany
- Investigational Site
-
Paderborn, Germany
- Investigational Site
-
Pasewalk, Germany
- Investigational Site
-
Pirna-Copitz, Germany
- Investigational Site
-
Prüm, Germany
- Investigational Site
-
Pulheim, Germany
- Investigational Site
-
Rastatt, Germany
- Investigational Site, Hindenburgstraße 10 A
-
Rastatt, Germany
- Investigational Site, Kaiserstraße 7
-
Ravensburg, Germany
- Investigational Site, Gartenstraße 22
-
Ravensburg, Germany
- Investigational Site, Grüner-Turm-Straße 7-9
-
Regensburg, Germany
- Investigational Site
-
Remscheid, Germany
- Investigational Site
-
Ribnitz-Damgarten, Germany
- Investigational Site
-
Rostock, Germany
- Investigational Site, Große Wasserstraße 2 - 3
-
Rostock, Germany
- Investigational Site, Nobelstraße 51
-
Rostock, Germany
- Investigational Site, Trelleborger Straße 10B
-
Rothenbach an der Pegnitz, Germany
- Investigational Site
-
Rottweil, Germany
- Investigational Site
-
Saarbrücken, Germany
- Investigational Site, Mainzer Straße 105
-
Saarbrücken, Germany
- Investigational Site, Viktoriastraße 2
-
Saarlouis, Germany
- Investigational Site
-
Salzmünde, Germany
- Investigational Site
-
Schwandorf, Germany
- Investigational Site
-
Schwerin, Germany
- Investigational Site
-
Schwerte, Germany
- Investigational Site
-
Schwäbisch Gmünd, Germany
- Investigational Site
-
Schönebeck, Germany
- Investigational Site
-
Senden, Germany
- Investigational Site
-
Sindelfingen, Germany
- Investigational Site
-
Spremberg, Germany
- Investigational Site, Kirchplatz 6a
-
Spremberg, Germany
- Investigational Site, Lustgartenstraße 3
-
Stockelsdorf, Germany
- Investigational Site
-
Stolberg, Germany
- Investigational Site
-
Stuttgart, Germany
- Investigational Site
-
Sulzbach-Rosenberg, Germany
- Investigational Site
-
Sömmerda, Germany
- Investigational Site
-
Tettnang, Germany
- Investigational Site
-
Tostedt, Germany
- Investigational Site
-
Trier, Germany
- Investigational Site
-
Troisdorf, Germany
- Investigational Site
-
Ulm, Germany
- Investigational Site, Hirschstraße 22
-
Ulm, Germany
- Investigational Site, Olgastraße 103
-
Ulm, Germany
- Investigational Site, Olgastraße 139
-
VS-Villingen, Germany
- Investigational Site
-
Velbert, Germany
- Investigational Site
-
Völklingen, Germany
- Investigational Site
-
Wangen, Germany
- Investigational Site
-
Weiden, Germany
- Investigational Site, Moosbürger Str. 13
-
Weiden, Germany
- Investigational Site, Postgasse 1
-
Weissenfels, Germany
- Investigational Site
-
Werl, Germany
- Investigational Site
-
Werningerode, Germany
- Investigational Site
-
Wesel, Germany
- Investigational Site
-
Wiesbaden, Germany
- Investigational Site
-
Wilhelmshaven, Germany
- Investigational Site
-
Wolfsburg, Germany
- Investigational Site, Heinrich-Nordhoff-Straße 49
-
Wolfsburg, Germany
- Investigational Site, Porschestraße 100
-
Würselen, Germany
- Investigational Site
-
Xanten, Germany
- Investigational Site
-
Zerbst, Germany
- Investigational Site
-
Überlingen, Germany
- Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with Advanced Hormone-dependent Prostate Carcinoma
Description
Inclusion Criteria:
- therapeutic need according to SPC
- written informed consent
Exclusion Criteria:
- contraindications according to SPC
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1
Patients with Advanced Hormone-dependent Prostate Carcinoma treated with Firmagon according to SPC
|
Non-interventional,observational Firmagon given by prescription according to SPC
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
duration of the PSA progression-free survival
Time Frame: open (until therapy end or stop)
|
open (until therapy end or stop)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
1. testosterone levels
Time Frame: open (until therapy end or stop)
|
open (until therapy end or stop)
|
2. number of ADRs and SUSARs
Time Frame: open (until therapy end or stop)
|
open (until therapy end or stop)
|
3. quality of life
Time Frame: open (until therapy end or stop)
|
open (until therapy end or stop)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Clinical Development Support, Ferring Pharmaceuticals
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
June 29, 2009
First Submitted That Met QC Criteria
June 29, 2009
First Posted (Estimated)
June 30, 2009
Study Record Updates
Last Update Posted (Estimated)
November 9, 2023
Last Update Submitted That Met QC Criteria
November 8, 2023
Last Verified
March 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FE200486 CS41
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma
-
Ferring PharmaceuticalsCompletedAdvanced Hormone Dependent Prostate CancerArgentina
-
University of OklahomaNot yet recruitingAndrogen Deprivation Therapy | Locally Advanced Prostate CancerUnited States
-
AstraZenecaCompletedPostoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) PatientsRussian Federation
-
Northwestern UniversityNational Cancer Institute (NCI); Vasgene Therapeutics, IncActive, not recruitingProgressive Disease | Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Adenocarcinoma | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone | Castration-Resistant Prostate Carcinoma Refractory to Second-Generation... and other conditionsUnited States
-
Universitaire Ziekenhuizen KU LeuvenAZ Sint-Jan AV; General Hospital Groeninge; AZ Sint-Blasius DendermondeRecruitingProstate Cancer | Adenocarcinoma of the Prostate | Locally Advanced Prostate Carcinoma | Locally Advanced Prostate AdenocarcinomaBelgium
-
Northwestern UniversityRecruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic CancerUnited States
-
Eye & ENT Hospital of Fudan UniversityRecruitingto Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal CarcinomaChina
-
STEBA FranceUniversity Health Network, TorontoCompletedRecurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy FailureCanada
-
RenJi HospitalNot yet recruitingProstate Cancer | Chemotherapy Effect | Hormone Sensitive Prostate Cancer | Locally Advanced Prostate Carcinoma
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
Clinical Trials on Firmagon given by prescription according to SPC
-
Nuria LloberasMinisterio de Sanidad, Servicios Sociales e IgualdadCompletedInfection in Solid Organ Transplant RecipientsSpain
-
Universitair Ziekenhuis BrusselRecruitingCochlear Implants | Sensorineural Hearing Loss, BilateralBelgium
-
Emine KAPLAN SERINCompleted
-
Kafkas UniversityRecruitingEmotional Disorder | Premenstrual Syndrome | Perceived StressTurkey
-
University Hospital, BrestTerminated
-
Tianjin Medical University Cancer Institute and...Tianjin Medical University General Hospital; Tianjin Medical University Second...Not yet recruitingHypopharyngeal CarcinomaChina
-
Central Hospital, Nancy, FranceRecruiting
-
The Federal Office for Radiation Protection, GermanySeibersdorf Labor GmbHCompleted
-
DUYGU DEMİROZInonu UniversityCompletedBody Weight Changes | Intubation Conditions | RocuroniumTurkey
-
Meshalkin Research Institute of Pathology of CirculationRecruitingCoronary Artery Disease | Surgery | Graft Failure | Coronary Artery Stenosis | Cardiac IschemiaRussian Federation